Cancer Diagnostics

Cancer Diagnostics, Inc. (CDI) is a long-established, private player in the anatomic pathology consumables market, headquartered in San Diego. Since its founding in 1998, it has built a portfolio centered on tissue marking dyes, specialized cutting boards, vapor-neutralizing pads, and other histology lab essentials, serving over 3,500 laboratories globally. The company operates a straightforward business model of manufacturing and distributing physical diagnostic supplies, positioning itself as a value-driven provider rather than a developer of novel diagnostic tests or platforms. Its outlook is tied to the steady demand for pathology lab consumables, though it faces competition from larger distributors and potential margin pressures.

Specialized formulation chemistry for histology-compatible tissue marking dyes and material science for laboratory safety/ergonomic consumables (e.g., vapor-neutralizing pads, cutting boards).

Competes in a fragmented market dominated by global giants like Thermo Fisher Scientific and Agilent, which offer extensive portfolios and distribution. Also competes with numerous smaller specialty distributors and manufacturers of histology consumables. CDI differentiates through specialization in tissue marking dyes and a focus on practical, user-friendly lab safety products.